Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - U.S. Stem Cell, Inc. | Financial_Report.xls |
10-Q - 10-Q - U.S. Stem Cell, Inc. | d31740.htm |
EX-31.1 - EX-31.1 - U.S. Stem Cell, Inc. | d31740_ex31-1.htm |
EX-10.81 - EX-10.81 - U.S. Stem Cell, Inc. | d31740_ex10-81.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL
FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Mike Tomas, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, Bioheart, Inc.s Quarterly Report on Form 10-Q for the
fiscal quarter ended September 30, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and
that
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: November 06, 2014 |
/s/Mike Tomas |
|||||||||
Name: |
Mike Tomas President and Chief Executive Officer Chief Financial Officer and Principal Accounting Officer |